2024-2025 Regular Session • New Jersey Legislature
A913
Legislative Summary
Authorizes medical cannabis for treatment of sickle cell anemia.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/9/2024
Introduced, Referred to Assembly Health Committee
General Assembly
3/6/2025
Reported and Referred to Assembly Appropriations Committee
General Assembly
3/20/2025
Reported out of Assembly Committee, 2nd Reading
General Assembly
Roll Call Votes
Assembly Appropriations Committee: Reported Favorably
3/20/2025
9
Yea
0
Nay
2
Not Voting
0
Absent
Result: PASSED
Assembly Health Committee: Reported Favorably
3/6/2025
9
Yea
1
Nay
1
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Introduced(1/9/2024)
Chamber
General Assembly
